We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Beximco Pharma | LSE:BXP | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 36.50 | 35.00 | 38.00 | 36.50 | 36.50 | 36.50 | 0 | 01:00:00 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/12/2021 15:17 | .....Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces the launch of the world's first generic version of Pfizer's COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir tablets, co-packaged for oral use) which was granted emergency use authorization (EUA) by the US FDA on 22 December 2021. Directorate General of Drug Administration (DGDA), Bangladesh, has today granted EUA for the oral antiviral drug to treat mild-to-moderate COVID-19 in adults and children of 12 years and above. This novel antiviral pill showed almost 90% efficacy in preventing hospitali z ations and deaths in high-risk patients, and recent data from Pfizer suggests the drug retains its effectiveness against the fast-spreading Omicron variant of the coronavirus. Beximco Pharma will market this product under the brand name Bexovid, initially in Bangladesh. | davebowler | |
30/12/2021 12:40 | What an announcement! World's first generic version of Pfizer pill. If this was a better known pharma market reaction would be off the scale. Quiet time generally for market news, hopefully we'll get very decent press coverage. Fantastic yield, chart breakout too, profitable and low enough p/e! For anybody who's not seen this.... | microscope | |
30/12/2021 11:14 | On dividend payment questions, the company did drop an RNS on Christmas Eve to say that it will be paid on or before the 20th January. My past experience is that it can take time to filter into accounts, so it may need some patience. | jim208 | |
30/12/2021 11:07 | great RNS today IMO. Hopefully, BXP can roll this out to other countries outside of Bangladesh. | mfhmfh | |
21/12/2021 16:20 | Sorry - Stocko's changed the payment date to 1/1/22 | podgyted | |
21/12/2021 16:16 | When is the dividend due to be paid - haven't rec'd mine yet | podgyted | |
10/12/2021 13:22 | Dave - thanks for that | cb7 | |
24/11/2021 21:03 | A small rise on today's vaccine media comment. Patience needed. Put in the drawer and come back late next year. | outsizeclothes.com | |
17/11/2021 00:01 | Our next Covid generic ????? | outsizeclothes.com | |
11/11/2021 12:42 | Great Q1 results. No wonder the company elected to pay the entire dividend in cash this year! And Q1 doesn’t included any vaccine uplift. Will analyse in more detail later. Solid hold | toadhall1 | |
11/11/2021 12:03 | Yes the Dividend is subject to 20% Bangladesh WHT | sayuri92 | |
09/11/2021 07:21 | Yes, unexpected but very impressive news should see a new high today.... :-) | cityfarmer | |
09/11/2021 07:15 | Launch of oral product for treating Covid.Although they don't anticipate a material impact on next numbers, if the product is approved in more countries (already approved in UK) I suspect that could and will change dramatically!Well done BXP! | microscope | |
08/11/2021 12:26 | Microscope, I'd agree that it looks like a cup and handle on the year to date chart. I'd be looking at an upwards channel as a shorter-term chart pattern, with a 105 break leading to 112 end of year target, and a June/July target of 130. | outsizeclothes.com | |
08/11/2021 12:08 | Sorry ceaser I simply don't know. Chart is close to a breakout. For the geeky, looks to me like a lovely cup and handle on the longer term chart may be completing | microscope | |
02/11/2021 19:12 | Is there withholding tax to pay on its dividend? | ceaserxzy | |
21/10/2021 13:39 | Lovely job! | microscope | |
21/10/2021 13:25 | Great results. All cash dividend too so showing the current strength of the business. | toadhall1 | |
21/10/2021 13:06 | 9.5p equiv. EPS for the year 3p equiv Divvy. I'll take that OK, thank you. | outsizeclothes.com | |
12/10/2021 13:38 | Looks like the "vaccine bonus" is now delayed until next year. BUT, with the likelihood of an annual booster being needed for larger parts of the population, Covid vaccine should be a recurring cash cow for the Company going forward. | outsizeclothes.com | |
05/10/2021 13:40 | Agree they are buys - was quoted 94.888 for £5k or 96p for £10k.. we should get a heads up on the full years results by end of this month. | pharma giles | |
05/10/2021 07:47 | Well now 2.54 (Taka) in Dhaka and if anything picking up speed over there. Although ADVFN showing lots of sells Fri and Mon at 94.5p here in London these were actually buys I know this as many were mine (again). With the Sanofi acquisition now in the bag and India releasing vaccines again (Oct-Dec) suspect we will get an announcement regarding AZ vaccine resume imports to Bangladesh any day. Am surprised we are still below a £1 here but I continue to fill my very full boots ........ | cityfarmer | |
22/9/2021 23:41 | Discount to Dhaka still at a historically wide level. A bargain, especially if the "30% of profits given back to shareholders" rule kicks in. | outsizeclothes.com | |
21/9/2021 12:39 | AMAR STOCK Beximco Pharma BXPHARMA: BARRON'S: Beximco Pharma BXPHARMA ANALYST ratings: BANGLADESH BANK: Website: | noirua |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions